as 12-20-2024 4:00pm EST
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
Founded: | 1997 | Country: | United States |
Employees: | N/A | City: | LANGHORNE |
Market Cap: | 22.7M | IPO Year: | 2021 |
Target Price: | N/A | AVG Volume (30 days): | 168.1K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.58 | EPS Growth: | N/A |
52 Week Low/High: | $1.84 - $5.10 | Next Earning Date: | 11-13-2024 |
Revenue: | $6,729,000 | Revenue Growth: | 90.57% |
Revenue Growth (this year): | 120.47% | Revenue Growth (next year): | 38.19% |
NXGL Breaking Stock News: Dive into NXGL Ticker-Specific Updates for Smart Investing
ACCESSWIRE
17 days ago
GlobeNewswire
a month ago
Simply Wall St.
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
TipRanks
2 months ago
GlobeNewswire
2 months ago
The information presented on this page, "NXGL NexGel Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.